WAM
GH icon

Wolverine Asset Management’s Guardant Health GH Stock Holding History

Wolverine Asset Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,985
Closed -$267K – 1674
2025
Q1 		$255K Sell
5,985
-2,600
-30% -$112K ﹤0.01% 979
2024
Q4 		$262K Sell
8,585
-22,377
-72% -$630K ﹤0.01% 980
2024
Q3 		$710K Buy
+30,962
New +$876K 0.01% 785
2024
Q2 		– Sell
-30,400
Closed -$708K – 1694
2024
Q1 		$627K Buy
+30,400
New +$652K 0.01% 772
2023
Q1 		– Sell
-2,996
Closed -$85.6K – 1969
2022
Q4 		$81.5K Buy
+2,996
New +$137K ﹤0.01% 1311
2021
Q3 		– Sell
-275
Closed -$32.7K – 2115
2021
Q2 		$34K Buy
+275
New +$37K ﹤0.01% 1773
2020
Q4 		– Sell
-2,408
Closed -$277K – 1734
2020
Q3 		$269K Sell
2,408
-122
-5% -$11.2K ﹤0.01% 904
2020
Q2 		$205K Buy
+2,530
New +$204K ﹤0.01% 919

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Asset Management's GH Position: Q2 2025 in Review

Wolverine Asset Management sold out of Guardant Health (GH) in Q2 2025, closing a stake of 5,985 shares — an estimated $267K sold.

Wolverine Asset Management first reported a position in GH in Q2 2020 and held it in 8 quarters. The position peaked at $710K in Q3 2024. 364 funds tracked by Wall St. Rank hold GH as of Q2 2025.

  • Wolverine Asset Management reported no remaining Guardant Health position as of Q2 2025 after selling out during the quarter.
  • Wolverine Asset Management sold 5,985 Guardant Health shares in Q2 2025, an estimated $267K.
  • Wolverine Asset Management first reported a position in Guardant Health in Q2 2020 and held it in 8 quarters.
  • Wolverine Asset Management's Guardant Health position peaked at $710K in Q3 2024.
  • 364 funds tracked by Wall St. Rank held Guardant Health as of Q2 2025.

Based on Wolverine Asset Management's 13F filing for Q2 2025, filed 4 Aug 2025.